DÄ internationalArchive51-52/2006Antivirals Are Not a Magic Solution, But an Important Tool in Planning for Pandemics


Antivirals Are Not a Magic Solution, But an Important Tool in Planning for Pandemics

Dtsch Arztebl 2006; 103(51-52): A-3484

Kurth, R; Buchholz, U; Haas, W

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Mounier-Jack S, Coker R: How prepared is Europe for pandemic influenza? Analysis of national plans. The Lancet 2006, 367: 1405–11.
2. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F: Impact of Oseltamivir Treatment on influenza-related lower respiratory tract complications and hospitalisations. Arch Intern Med 2003; 163: 1667–71. MEDLINE
3. Govorkova E, Leneva I, Goloubeva O, Bush K, Webster R: Comparison of efficacies of RWJ-270201, Zanamivir and Oseltamivir against H5N1, H9N2 and other avian Influenza viruses. Antimicrob Agents Chemother. 2001; 45: 2723–32. MEDLINE
4. Leneva IA, Roberts N, Govorkova EA, Goloubeva OG, Webster RG: The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. Antiviral Res. 2000; 48(2): 101–15. MEDLINE
5. Ward P, Small I, Smith J, Suter P, Dutkowski R: Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother. 2005; 55 (Suppl 1): i5–21. MEDLINE
6. Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, Dutkowski R, Ward P, Carr J: Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis 2004; 189(3): 440–49. MEDLINE
7. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M: Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 2006; 50(7): 2395–402.
8. Kiso M, Mitamura K, Sakai-Tagawa Y et al.: Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004; 364: 759–65. MEDLINE